Delivery Order SPE2DX22D0010-SPE2D823FDP74
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.00 firm fixed-price delivery order is for the supply of 4566779797 - Oxymorphone HCL ER 20 MG Tablets in 60-count packages. The contract has a completion date of December 23, 2024. This award is associated with Amerisourcebergen's...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.02 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER Tablets, 7.5 mg, with a period of performance through February 10, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,679.80, is a delivery order for the supply of 4567075298 - Oxymorphone HCL ER Tabs 10mg. The contract has a firm fixed price pricing type and a period of performance through January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $3,817.34 for the supply of Oxymorphone HCL ER Tabs 20mg. The contract has an ultimate completion date of June 27, 2024 and a firm fixed price pricing type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was awarded this contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,672.25, is a firm fixed price delivery order for 4,564,082,819 units of Oxymorphone Hydrochloride Extended-Release Tablets 40mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,108.13 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER Tablets, 7.5mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive...
- This federal contract award, valued at $2,429.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Oxymorphone HCL ER Tablets 40mg, a pain management medication. This is a Firm Fixed Price contract with a completion date of December 27, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $3,227.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxymorphone HCL ER Tablets, 20mg, a pain management medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.10 firm fixed-price delivery order is for 4566339699 - Oxymorphone HCL ER 10 MG Tablets, 100 per bottle. The contract has a period of performance through November 6, 2024 and was not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.49 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 24, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D823FDP74Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,213.40 firm fixed-price delivery order is for the supply of 4559781652 - Oxymorphone HCL ER Tablets 30mg. The contract has an ultimate completion date of February 1, 2023 and was awarded on January 31, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, plays a critical role in supplying essential medical products to federal government agencies, including the military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 1/31/23 |